Y. Kusunoki

发表

Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus

M. Namba, C. Inokuchi, T. Hamaguchi, 2009, The Journal of international medical research.

Insulin resistance and β-cell function influence postprandial blood glucose levels in Japanese patients with gestational diabetes mellitus

M. Namba, J. Miyagawa, T. Katsuno, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes.

H. Watada, T. Kitamura, Masaki Kobayashi, 2020, Endocrine journal.

New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy

M. Namba, J. Miyagawa, T. Katsuno, 2013, Clinical and Experimental Nephrology.

Xanthine oxidoreductase activity is correlated with hepatic steatosis

H. Koyama, Manabu Kadoya, Miki Kakutani-Hatayama, 2021, Scientific Reports.

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Therapeutics and clinical risk management.

Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2011, Endocrine journal.

Study of glucagon response and its association with glycemic control and variability after administration of ipragliflozin as an adjunctive to insulin treatment in patients with type 1 diabetes (Suglat-AID)

T. Kitamura, Masaki Kobayashi, Y. Hirota, 2021, Medicine: Case Reports and Study Protocols.

Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Journal of diabetes investigation.

Response of incretins (GIP and GLP-1) to an oral glucose load in female and male subjects with normal glucose tolerance.

M. Namba, J. Miyagawa, T. Katsuno, 2014, Diabetes research and clinical practice.

Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes.

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Endocrine journal.

Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data

M. Namba, J. Miyagawa, T. Katsuno, 2014, Drugs in R&D.

Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes

H. Koyama, M. Namba, T. Murase, 2019, Acta Diabetologica.

Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.

Y. Moriwaki, Tetsuya Yamamoto, H. Koyama, 2017, Metabolism: clinical and experimental.

Incretin responses to oral glucose load in Japanese non-obese healthy subjects

M. Namba, T. Hamaguchi, J. Miyagawa, 2011, Diabetes therapy : research, treatment and education of diabetes and related disorders.

Sleep Apnea and Diabetes Predict Progression of Cardiac Diastolic Dysfunction in Pre-heart Failure Patients: a Prospective Cohort HSCAA Study

H. Koyama, M. Asakura, Manabu Kadoya, 2020 .

Sleep Apnea and Physical Movement During Sleep, But Not Sleep Duration, Are Independently Associated With Progression of Left Ventricular Diastolic Dysfunction: Prospective Hyogo Sleep Cardio‐Autonomic Atherosclerosis Cohort Study

H. Koyama, M. Asakura, Manabu Kadoya, 2022, Journal of the American Heart Association.

Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, Drugs in R&D.

A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine

M. Namba, J. Miyagawa, T. Katsuno, 2016, Acta Diabetologica.

Significance of Glycemic Variability in Diabetes Mellitus

H. Koyama, K. Konishi, Y. Kusunoki, 2021, Internal medicine.

Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin.

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Endocrine journal.

Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

H. Koyama, M. Namba, T. Katsuno, 2020, Journal of diabetes investigation.

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

M. Namba, T. Hamaguchi, J. Miyagawa, 2013, Diabetes Therapy.

Associations of sleep quality, sleep apnea and autonomic function with insulin secretion and sensitivity: HSCAA study

H. Koyama, Manabu Kadoya, Miki Kakutani-Hatayama, 2020, Metabolism open.

Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2015, World journal of experimental medicine.

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay

M. Namba, J. Miyagawa, T. Katsuno, 2015, Journal of diabetes investigation.

Evaluation of blood glucose fluctuation in Japanese patients with type 1 diabetes mellitus by self-monitoring of blood glucose and continuous glucose monitoring.

M. Namba, J. Miyagawa, T. Katsuno, 2015, Diabetes research and clinical practice.

Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study

H. Koyama, H. Ikeda, T. Katsuno, 2020, Journal of diabetes investigation.

Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges

Manabu Kadoya, Akinori Kanzaki, M. Namba, 2023, Journal of diabetes investigation.

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients

M. Namba, T. Hamaguchi, J. Miyagawa, 2014 .

Sleep quality, autonomic dysfunction and renal function in diabetic patients with pre-CKD phase

H. Koyama, Manabu Kadoya, Miki Kakutani-Hatayama, 2021, Scientific Reports.

Nocturnal hypertension and left ventricular diastolic dysfunction in diabetic patients with pre-heart failure phase: Prospective cohort HSCAA study

Manabu Kadoya, Akinori Kanzaki, M. Ishihara, 2023, medRxiv.

Nocturnal Hypertension and Left Ventricular Diastolic Dysfunction in Patients With Diabetes With the Absence of Heart Failure: Prospective Cohort HSCAA Study

Manabu Kadoya, Akinori Kanzaki, Miki Kakutani-Hatayama, 2023, Hypertension.

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study

T. Kitamura, Y. Hirota, Tomoyasu Fukui, 2024, Diabetes, obesity & metabolism.

Prevention of Worsening Diabetes through Behavioral Changes by an IoT-based Self-Monitoring System in Japan (PRISM-J): Study design and rationale for a multicenter, open-label, randomized parallel-group trial

Shigeho Tanaka, K. Miyo, T. Kadowaki, 2021, GHM Open.

Association between brain imaging biomarkers and continuous glucose monitoring-derived glycemic control indices in Japanese patients with type 2 diabetes mellitus

Manabu Kadoya, T. Katsuno, K. Konishi, 2024, BMJ Open Diabetes Research & Care.